Low maruyama index surgery for gastric cancer: Blinded reanalysis of the dutch D1-D2 trial

World Journal of Surgery

Volumn 29, Issue 12, 2005, Pages 1576-1584

  Peeters, K C M J ^a   Hundahl, S A ^b,c   Kranenbarg, E Klein ^a   Hartgrink, H ^a   Van De Velde, C J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; QUANTITATIVE ANALYSIS; STOMACH CARCINOMA; UNITED STATES;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; SINGLE-BLIND METHOD; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 19644374382     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-7907-9     Document Type: Article

References (26)

1. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725.
2. Kelsen DP. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. J Clin Oncol 2000;18:32S-4S.
3. Macdonald JS, Smalley S, Benedetti J, et al. Posptoperative combined radiation and chemotherapy improves disease-free (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update of the results of Intergroup Study INT-0116 (SWOG 9008). Abstract 6 and oral presentation at ASCO Gastrointestinal Cancers Symposium, San Francisco, California, Jan. 2004 (web available at http://www.asco.org.
4. Hundahl SA, Macdonald JS, Benedetti J, et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002;9:278.
5. Kampschoer GH, Maruyama K, van de Velde CJ, et al. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 1989;76:905.
6. Japanese Classification of Gastric Carcinoma, First English Edition. Tokyo, Kanehara, 1995.
7. Siewert JR, Kelsen D, Maruyama K, et al. Gastric Cancer Diagnosis and Treatment - an Interactive Training Program New York, Springer Electronic Media 2000.
8. Bollschweiler E, Boettcher K, Hoelscher AH, et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br J Surg 1992;79:156.
9. Guadagni S, de Manzoni G, Catarci M, et al. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer. World J. Surg. 2000;24:1550.
10. Hundahl SA, Macdonald JS, Benedetti J. Durable Survival Impact of "Low Maruyama Index Surgery" in a Trial of Adjuvant Chemoradiation for Gastric Cancer, 48. San Francisco,2004 ASCO GI Symposium, 2004.
11. Hartgrink HH, Van De Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial. J Clin Oncol 2004;22:2069.
12. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer: Dutch Gastric Cancer Group. N Engl J Med 1999;340:908.
13. Bunt AM, Hermans J, Boon MC, et al. Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol 1994;12:417.
14. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988;75:110.
15. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long- term results of the MRC randomized surgical trial: Surgical Cooperative Group. Br J Cancer 1999;79:1522.
16. Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study. Ann Surg 1989;209:162.
17. Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176.
18. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial: Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170.
19. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial: he Surgical Cooperative Group. Lancet 1996;347:995.
20. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 1997;84:1567.
21. Bunt TM, Bonenkamp HJ, Hermans J, et al. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer 1994;73:1544.
22. Maruyama K, Sasako M, Kinoshita T, et al. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995;19:532.
23. Doglietto GB, Pacelli F, Caprino P, et al. Pancreas-preserving total gastrectomy for gastric cancer. Arch Surg 2000;135:89.
24. Lisborg P, Jatzko G, Horn M, et al. Radical surgery (R2 resection) for gastric cancer: a multivariate analysis. Scand J Gastroenterol 1994;29:1024.
25. Brady MS, Rogatko A, Dent LL, et al. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 1991;126:359.
26. Kranenbarg EK, van de Velde CJ. Gastric cancer in the elderly. Eur J Surg Oncol 1998;24:384.